Buy Dr Reddy's Laboratories, target price Rs 3,270: Dharmesh Shah
The analyst suggested a stoploss at Rs 3065 .

Dr. Reddy's Laboratories Ltd., incorporated in 1984, has a market cap of Rs 52257.80 crore.
Dr. Reddy's Laboratories' key products/revenue segments include Pharmaceuticals which contributed Rs 10466.70 crore to sales value (98.50 per cent of total sales); Licence Fees which contributed Rs 55.90 crore to sales value (0.52 per cent of total sales); Service Income which contributed Rs 50.30 crore to sales value (0.47 per cent of total sales); Spent Chemicals which contributed Rs 35.60 crore to sales value (0.33 per cent of total sales); Scrap which contributed Rs 16.10 crore to sales value (0.15 per cent of total sales) and Other Operating Revenue which contributed Rs .90 crore to sales value (0.00 per cent of total sales)for the year ending March 31, 2019.
For the quarter ended December 31, 2019, the company reported consolidated sales of Rs 4383.80 crore, down -8.69 per cent from last quarter sales of Rs 4800.80 crore and up 15.79 per cent from last year same quarter sales of Rs 3786.10 crore. The company reported net profit after tax of Rs -556.00 crore in the latest quarter.
Download ET Markets APP